nach oben

Journal of Diabetes & Metabolic Disorders

Erschienen in:

27.01.2022 | Research article

Assessment of resveratrol on diabetes of zebrafish (Danio rerio)

verfasst von: Mina Faal, Hamed Manouchehri, Reza Changizi, Fatemeh Bootorabi, Mohammad Reza Khorramizadeh

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Zebrafish (Danio rerio) is an established model for studying various metabolic diseases. The aim of this study was to evaluate the effect of resveratrol as a natural polyphenol on reducing inflammation caused by hyperglycemia (diabetes) and its effect on digestive tissue as well as TNF-α, IFN-γ, and INL1β genes in zebrafish.

Methods

Within a 20-day period, the research was performed on 120 adult zebrafish, which were randomly classified into eight groups: two experimental treatments (induced glucose = +G) and (without glucose = −G), where each main group was as follows: CTRL = control and RSV resveratrol with doses 10, 20, and 30 μmol/L. At the end of the period, the blood glucose level was measured using glucose test strip, staining of intestinal tissue was done by hematoxylin and eosin (H&E), and expression of INF-γ, IL1-β, and TNF-α genes extracted from the intestinal was measured via internal method RT-PCR. Data analysis in this study was performed using SPSS software version 21. One-way ANOVA and mean comparison of treatments by Duncan test were used for data analysis. All statistical analyses were performed at a significant level (P < 0.5) where the mean data were presented with standard deviation.

Results

According to the results, the lowest blood sugar level at the end of the experiment belonged to the group (G-RSV20) where no significant difference was observed between treatments (P > 0.05). The highest expression of IL1-β gene belonged to the (G + CTRL) group (P < 0.05), while the (G + RSV20) group showed the lowest expression of the INF-γ gene and had a significant difference with other groups (P < 0.05). In (G + RSV10) treatment, the lowest expression of TNF-α gene was observed and there was no significant difference with other treatments (P > 0.05). Resveratrol would improve the absorption of nutrients in the intestinal tissue by increasing the number of goblet cells as well as the width and height of the villi.

Conclusion

Collectively, this study indicated that treatment with resveratrol could improve metabolic-mediated performances by reducing blood glucose, increasing food absorption in the intestine tissue, and reducing the expression of inflammatory genes in type 2 diabetic zebrafish model.

Killingley J. Diabetic retinopathy: examining pericyte-endothelial ratios using zebrafish and rat retinas (laboratory research and background literature review): American University; 2010.

Diabetes facts and figures. International Diabetes Federation. 2020.

Barbazuk WB, Korf I, Kadavi C, Heyen J, Tate S, Wun E, et al. The syntenic relationship of the zebrafish and human genomes. Genome Res. 2000;10(9):1351–8. https://doi.org/10.1101/gr.144700.CrossRefPubMedPubMedCentral

Zang L, Shimada Y, Nishimura N. Development of a novel zebrafish model for type 2 diabetes mellitus. Sci Rep. 2017;7(1):1–11. https://doi.org/10.1038/s41598-017-01432-w.CrossRef

Pan MH, Wu JC, Ho CT, Lai CS. Antiobesity molecular mechanisms of action: resveratrol and pterostilbene. BioFactors. 2018;44(1):50–60. https://doi.org/10.1002/biof.1409.CrossRefPubMed

Elshaer M, Chen Y, Wang XJ, Tang X. Resveratrol: an overview of its anti-cancer mechanisms. Life Sci. 2018;207:340–9. https://doi.org/10.1016/j.lfs.2018.06.028.CrossRefPubMed

Szkudelski T, Szkudelska K. Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta. 2015;1852(6):1145–54. https://doi.org/10.1016/j.bbadis.2014.10.013.CrossRefPubMed

Brasnyó P, Molnár GA, Mohás M, Markó L, Laczy B, Cseh J, et al. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr. 2011;106(3):383–9. https://doi.org/10.1017/S0007114511000316.CrossRefPubMed

Chang C-C, Chang C-Y, Wu Y-T, Huang J-P, Yen T-H, Hung L-M. Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase. J Biomed Sci. 2011;18(1):1–10.CrossRef

10.

Um J-H, Park S-J, Kang H, Yang S, Foretz M, McBurney MW, et al. AMP-activated protein kinase–deficient mice are resistant to the metabolic effects of resveratrol. Diabetes. 2010;59(3):554–63. https://doi.org/10.2337/db09-0482.CrossRefPubMed

11.

Chu W-M. Tumor necrosis factor. Cancer Lett. 2013;328(2):222–5. https://doi.org/10.1016/j.canlet.2012.10.014.CrossRefPubMed

12.

Abbas AK, Lichtman AH, Pober J. Cellular and molecular immunology. 7th ed. Philadelphia, PA: Elsevier/Saunders; 2011.

13.

Peñalver P, Belmonte-Reche E, Adán N, Caro M, Mateos-Martín ML, Delgado M, et al. Alkylated resveratrol prodrugs and metabolites as potential therapeutics for neurodegenerative diseases. Eur J Med Chem. 2018;146:123–38. https://doi.org/10.1016/j.ejmech.2018.01.037.CrossRefPubMed

14.

Kowalska A, Siwicki AK, Kowalski RK. Dietary resveratrol improves immunity but reduces reproduction of broodstock medaka Oryzias latipes (Temminck & Schlegel). Fish Physiol Biochem. 2017;43(1):27–37. https://doi.org/10.1007/s10695-016-0265-8.CrossRefPubMed

15.

Tseng Y-C, Chen R-D, Lee J-R, Liu S-T, Lee S-J, Hwang P-P. Specific expression and regulation of glucose transporters in zebrafish ionocytes. Am J Physiol Regul Integr Comp Physiol. 2009;297(2):R275–R90. https://doi.org/10.1152/ajpregu.00180.2009.CrossRefPubMed

16.

Elo B, Villano C, Govorko D, White L. Larval zebrafish as a model for glucose metabolism: expression of phosphoenolpyruvate carboxykinase as a marker for exposure to anti-diabetic compounds. J Mol Endocrinol. 2007;38(4):433–40. https://doi.org/10.1677/JME-06-0037.CrossRefPubMed

17.

Ran G, Ying L, Li L, Yan Q, Yi W, Ying C, et al. Resveratrol ameliorates diet-induced dysregulation of lipid metabolism in zebrafish (Danio rerio). PLoS One. 2017;12(7):e0180865. https://doi.org/10.1371/journal.pone.0180865.CrossRefPubMedPubMedCentral

18.

Gleeson M, Connaughton V, Arneson L. Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina. Acta Diabetol. 2007;44(3):157–63. https://doi.org/10.1007/s00592-007-0257-3.CrossRefPubMed

19.

Eames SC, Philipson LH, Prince VE, Kinkel MD. Blood sugar measurement in zebrafish reveals dynamics of glucose homeostasis. Zebrafish. 2010;7(2):205–13. https://doi.org/10.1089/zeb.2009.0640.CrossRefPubMedPubMedCentral

20.

Velma V, Tchounwou PB. Chromium-induced biochemical, genotoxic and histopathologic effects in liver and kidney of goldfish, Carassius auratus. Mutat Res Genet Toxicol Environ Mutagen. 2010;698(1-2):43–51. https://doi.org/10.1016/j.mrgentox.2010.03.014.CrossRef

21.

Liu X-J, Luo Z, Li C-H, Xiong B-X, Zhao Y-H, Li X-D. Antioxidant responses, hepatic intermediary metabolism, histology and ultrastructure in Synechogobius hasta exposed to waterborne cadmium. Ecotox Environ Safe. 2011;74(5):1156-63. https://doi.org/10.1016/j.ecoenv.2011.02.015.

22.

Wang S-z, Liu B-h, Tao HW, Xia K, Zhang LI. A genetic strategy for stochastic gene activation with regulated sparseness (STARS). PLoS ONE. 2009;4(1):e4200. 10.1371/journal.pone.0004200.

23.

Duncan D. Multiple range and multiple F tests. Biometrics. 1995. https://doi.org/10.2307/3001478.

24.

Stone DA. Dietary carbohydrate utilization by fish. Rev Fish Sci. 2003;11(4):337-69. 10.1080/10641260390260884.

25.

Robison BD, Drew RE, Murdoch GK, Powell M, Rodnick KJ, Settles M, et al. Sexual dimorphism in hepatic gene expression and the response to dietary carbohydrate manipulation in the zebrafish (Danio rerio). Comp Biochem Physiol D: Genomics Proteomics. 2008;3(2):141–54. https://doi.org/10.1016/j.cbd.2008.01.001.CrossRefPubMed

26.

González-Alvarez R, Ortega-Cuellar D, Hernández-Mendoza A, Moreno-Arriola E, Villaseñor-Mendoza K, Gálvez-Mariscal A, et al. The hexokinase gene family in the zebrafish: structure, expression, functional and phylogenetic analysis. Comp Biochem Physiol B: Biochem Mol Biol. 2009;152(2):189–95. https://doi.org/10.1016/j.cbpb.2008.11.004.CrossRef

27.

Fiori JL, Shin Y-K, Kim W, Krzysik-Walker SM, González-Mariscal I, Carlson OD, et al. Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet. Diabetes. 2013;62(10):3500–13. https://doi.org/10.2337/db13-0266.CrossRefPubMedPubMedCentral

28.

Yang J, Holman GD. Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology. 2006;147(6):2728–36. https://doi.org/10.1210/en.2005-1433.CrossRefPubMed

29.

Green BD, Irwin N, Duffy NA, Gault VA, O'Harte FP, Flatt PR. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1. Eur J Pharmacol. 2006;547(1-3):192–9. https://doi.org/10.1016/j.ejphar.2006.07.043.CrossRefPubMed

30.

Park J, Um JI, Jo A, Lee J, Jung D-W, Williams DR, et al. Impact of molecular charge on GLUT-specific cellular uptake of glucose bioprobes and in vivo application of the glucose bioprobe, GB2-Cy3. Chem Commun. 2014;50(66):9251–4. https://doi.org/10.1039/c4cc00955j.CrossRef

31.

Appleton J. Evaluating the bioavailability of isoquercetin. Nat Med J. 2010;2(1):1–6.

32.

Tabassum N, Tai H, Jung D-W, Williams DR. Fishing for nature’s hits: establishment of the zebrafish as a model for screening antidiabetic natural products. Evid-Based Compl Alt. 2015;2015. https://doi.org/10.1155/2015/287847.

33.

Dorsemans A-C, d'Hellencourt CL, Ait-Arsa I, Jestin E, Meilhac O, Diotel N. Acute and chronic models of hyperglycemia in zebrafish: a method to assess the impact of hyperglycemia on neurogenesis and the biodistribution of radiolabeled molecules. J Vis Exp. 2017;124:e55203. https://doi.org/10.3791/55203.CrossRef

34.

Dorsemans AC, Soulé S, Weger M, Bourdon E, Lefebvre d'Hellencourt C, Meilhac O, et al. Impaired constitutive and regenerative neurogenesis in adult hyperglycemic zebrafish. J Comp Neurol. 2016;525(3):442–58. https://doi.org/10.1002/cne.24065.CrossRefPubMed

35.

Podlasz P, Sallinen V, Chen YC, Kudo H, Fedorowska N, Panula P. Galanin gene expression and effects of its knock-down on the development of the nervous system in larval zebrafish. J Comp Neurol. 2012;520(17):3846–62. https://doi.org/10.1002/cne.23131.CrossRefPubMed

36.

Tatemoto K, Rökaeus Å, Jörnvall H, McDonald TJ, Mutt V. Galanin—a novel biologically active peptide from porcine intestine. FEBS Lett. 1983;164(1):124–8. https://doi.org/10.1016/0014-5793(83)80033-7.CrossRefPubMed

37.

Podlasz P, Jakimiuk A, Chmielewska-Krzesinska M, Kasica N, Nowik N, Kaleczyc J. Galanin regulates blood glucose level in the zebrafish: a morphological and functional study. Histochem Cell Biol. 2016;145(1):105–17. https://doi.org/10.1007/s00418-015-1376-5.CrossRefPubMed

38.

Quynh NTT, Islam SM, Florén A, Bartfai T, Langel Ü, Östenson C-G. Effects of galnon, a non-peptide galanin-receptor agonist, on insulin release from rat pancreatic islets. Biochem Biophys Res Commun. 2005;328(1):213–20. https://doi.org/10.1016/j.bbrc.2004.12.150.CrossRefPubMed

39.

Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, et al. Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci. 2002;99(10):7136–41. https://doi.org/10.1073/pnas.102163499.CrossRefPubMedPubMedCentral

40.

Laudadio V, Dambrosio A, Normanno G, Khan RU, Naz S, Rowghani E, et al. Effect of reducing dietary protein level on performance responses and some microbiological aspects of broiler chickens under summer environmental conditions. Avian Biol Res. 2012;5(2):88–92. https://doi.org/10.3184/175815512X13350180713553.CrossRef

41.

Tufarelli V, Desantis S, Zizza S, Laudadio V. Performance, gut morphology and carcass characteristics of fattening rabbits as affected by particle size of pelleted diets. Arch Anim Nutr. 2010;64(5):373–82. https://doi.org/10.1080/1745039X.2010.496945.CrossRefPubMed

42.

Franco J, Murakami A, Natali M, Garcia E, Furlan A. Influence of delayed placement and dietary lysine levels on small intestine morphometrics and performance of broilers. Braz J Poult Sci. 2006;8(4):233–41. https://doi.org/10.1590/S1516-635X2006000400006.CrossRef

43.

Forstner J, Oliver M, Sylvester F. Production, structure and biologic relevance of gastrointestinal mucins. Infect Gastrointest Tract. 1995;1995:71–88.

44.

Ferreira PM, Caldas DW, Salaro AL, Sartori SS, Oliveira JM, Cardoso AJ, et al. Intestinal and liver morphometry of the yellow tail tetra (Astyanax altiparanae) fed with oregano oil. An Acad Bras Cienc. 2016;88(2):911–22. https://doi.org/10.1590/0001-3765201620150202.CrossRefPubMed

45.

Franz C, Baser K, Windisch W. Essential oils and aromatic plants in animal feeding–a European perspective. A review Flavour Frag J. 2010;25(5):327–40. https://doi.org/10.1002/ffj.1967.CrossRef

46.

Faccioli CK, Chedid RA, do Amaral AC, IBF V, Vicentini CA. Morphology and histochemistry of the digestive tract in carnivorous freshwater Hemisorubim platyrhynchos (Siluriformes: Pimelodidae). Micron. 2014;64:10–9. https://doi.org/10.1016/j.micron.2014.03.011.CrossRefPubMed

47.

Kandori H, Hirayama K, Takeda M, DOI K. Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. Exp Anim. 1996;45(2):155–60. https://doi.org/10.1538/expanim.45.155.CrossRefPubMed

48.

Khan W, Collins S. Immune-mediated alteration in gut physiology and its role in host defence in nematode infection. Parasite Immunol. 2004;26(8-9):319–26. https://doi.org/10.1111/j.0141-9838.2004.00715.x.CrossRefPubMed

49.

Ghazanfari S, Mohammadi Z, Adib MM. Effects of coriander essential oil on the performance, blood characteristics, intestinal microbiota and histological of broilers. Braz J Poult Sci. 2015;17(4):419–26. https://doi.org/10.1590/1516-635x1704419-426.CrossRef

50.

Festa A, D’Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102(1):42–7. https://doi.org/10.1161/01.CIR.102.1.42.CrossRefPubMed

51.

Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98–107. https://doi.org/10.1038/nri2925.CrossRefPubMed

52.

Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2018;119(1):105–10. https://doi.org/10.1002/jcb.26174.CrossRefPubMed

53.

Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 2014;34(10):837–43. https://doi.org/10.1016/10.1016/j.nutres.2014.09.005.CrossRefPubMed

54.

Nisoli E, Briscini L, Giordano A, Tonello C, Wiesbrock SM, Uysal KT, et al. Tumor necrosis factor α mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity. Proc Natl Acad Sci. 2000;97(14):8033–8. https://doi.org/10.1073/pnas.97.14.8033.CrossRefPubMedPubMedCentral

55.

Morey M, O'Gaora P, Pandit A, Hélary C. Hyperglycemia acts in synergy with hypoxia to maintain the pro-inflammatory phenotype of macrophages. PLoS One. 2019;14(8):e0220577. https://doi.org/10.1371/journal.pone.0220577.CrossRefPubMedPubMedCentral

56.

Moura-Assis A, Afonso MS, de Oliveira V, Morari J, dos Santos GA, Koike M, et al. Flaxseed oil rich in omega-3 protects aorta against inflammation and endoplasmic reticulum stress partially mediated by GPR120 receptor in obese, diabetic and dyslipidemic mice models. J Nutr Biochem. 2018;53:9–19. https://doi.org/10.1016/j.jnutbio.2017.09.015.CrossRefPubMed

57.

Zhu L, Sha L, Li K, Wang Z, Wang T, Li Y, et al. Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats. Lipids Health Dis. 2020;19(1):1–16. https://doi.org/10.1186/s12944-019-1167-4.CrossRef

58.

Szkudelska K, Okulicz M, Hertig I, Szkudelski T. Resveratrol ameliorates inflammatory and oxidative stress in type 2 diabetic Goto-Kakizaki rats. Biomed Pharmacother. 2020;125:110026. https://doi.org/10.1016/j.biopha.2020.110026.CrossRefPubMed

59.

Poulsen MM, Fjeldborg K, Ornstrup MJ, Kjær TN, Nøhr MK, Pedersen SB. Resveratrol and inflammation: challenges in translating pre-clinical findings to improved patient outcomes. Biochim Biophys Acta. 2015;1852(6):1124–36. https://doi.org/10.1016/j.bbadis.2014.12.024.CrossRefPubMed

60.

Zhao G, Dharmadhikari G, Maedler K, Meyer-Hermann M. Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies. PLoS Comput Biol. 2014;10(8):e1003798. https://doi.org/10.1371/journal.pcbi.1003798.CrossRefPubMedPubMedCentral

61.

Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European prospective investigation into Cancer and nutrition (EPIC)-Potsdam study. Diabetes. 2003;52(3):812–7. https://doi.org/10.2337/diabetes.52.3.812.CrossRefPubMed

62.

Sromova L, Busek P, Mareckova H, Andel M, Sedo A. The effect of dipeptidyl peptidase-IV inhibitor sitagliptin on the immune functions in patients with type 2 diabetes. Front Immunol. 2013. https://doi.org/10.3389/conf.fimmu.2013.02.00154.

63.

Satoh-Asahara N, Sasaki Y, Wada H, Tochiya M, Iguchi A, Nakagawachi R, et al. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. Metabolism. 2013;62(3):347–51. https://doi.org/10.1016/j.metabol.2012.09.004.CrossRefPubMed

64.

Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 2007;8:353–67. https://doi.org/10.1038/nrg2091.CrossRefPubMed

65.

Asha S, Derek LS, Ines B. The emerging use of zebrafish to model metabolic disease 2013. https://doi.org/10.1242/dmm.011346.

66.

Sanchez-Fidalgo S, Cardeno A, Villegas I, Talero E, de la Lastra CA. Dietarysupplementation of resveratrol attenuates chronic colonic inflammation in mice. Eur J Pharmacol. 2010;633:78–84.30. https://doi.org/10.1016/j.ejphar.2010.01.025.CrossRefPubMed

67.

Bereswill S, Munoz M, Fischer A, Plickert R, Haag L-M et al. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLos ONE 5 2010.(12):e15099. https://doi.org/10.1371/journal.pone.0015099.

68.

Bagul P, Banerjee S. Application of resveratrol in diabetes: rationale, strategies and challenges. Curr Mol Med. 2015;15(4):312–30. https://doi.org/10.2174/1566524015666150505155702.CrossRefPubMed

69.

Marouf BH, Aziz TA, Zalzala MH, Hussain SA. Free radical scavenging activity of Benfotiamine in nitriteinduced hemoglobin oxidation and membrane fragility models. J Pharm Biomed Sci. 2010;1(1):13–8.

70.

Bhullar KS, Hubbard BP. Lifespan and healthspan extension by resveratrol. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2015;1852(6):1209-18. https://doi.org/10.1016/j.bbadis.2015.01.012

71.

Movahed A. Beneficial effects of resveratrol on reducing blood glucose and insulin resistance in T2DM. ISMJ. 2016;19(1):155–66.

Titel: Assessment of resveratrol on diabetes of zebrafish (Danio rerio)
verfasst von: Mina Faal
Hamed Manouchehri
Reza Changizi
Fatemeh Bootorabi
Mohammad Reza Khorramizadeh
Publikationsdatum: 27.01.2022
Verlag: Springer International Publishing
Erschienen in: Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2022
Elektronische ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-021-00964-3

High prevalence of diabetes in elderly of Iran: an urgent public health issue

Research article

Comparison of catalase, glutathione peroxidase and malondialdehyde levels in tears among diabetic patients with and without diabetic retinopathy

Research article

SELF-CARE AND QUALITY OF LIFE PEOPLE WITH TYPE 2 DIABETES DURING THE COVID-19: CROSS-SECTIONAL STUDY

COVID-19
Research article

The importance of personalized medicine in urological cancers

Review article

Genetic variants of ALR (-106C → T /-12C → G) and serum PKC-δ are associated with peripheral neuropathy in Egyptian diabetic patients with impaired handwriting

Research article

Experiences from the management of COVID-19 pandemic in a nursing home in Iran (March–April, 2020)

Zur Zeit gratis
COVID-19
Commentary

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Lp(a) zur Risikoeinschätzung bei Thoraxschmerzen

20.01.2025
Koronare Herzerkrankung
Nachrichten

Der Lp(a)-Wert kann dazu beitragen, bei stabilen Patienten mit neu aufgetretenen Thoraxschmerzen und ohne KHK-Diagnose die Wahrscheinlichkeit für das Vorliegen von Koronarstenosen abzuschätzen.

Finerenon bei eGFR-Verlust nicht gleich absetzen!

20.01.2025
Chronische Herzinsuffizienz
Nachrichten

Der Mineralokortikoid-Rezeptor-Antagonist Finerenon verbessert die Prognose bei Herzinsuffizienz mit leicht reduzierter oder erhaltener Ejektionsfraktion. Ein Rückgang der eGFR zu Beginn der Therapie scheint diese Wirkung nicht wesentlich zu mindern.

Polypen bei nahen Verwandten – erhöhtes Darmkrebsrisiko

20.01.2025
Risikofaktoren für Krebserkrankungen
Nachrichten

Werden bei erstgradigen Verwandten gutartige Darmpolypen identifiziert, ist das Risiko, selbst an einem Kolorektalkarzinom zu erkranken, deutlich erhöht – vor allem das für eine früh beginnende Erkrankung. Hier könnte sich eine frühe Koloskopie besonders lohnen.

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

17.01.2025
Dekubitus
Nachrichten

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Assessment of resveratrol on diabetes of zebrafish (Danio rerio)